MEMPHIS, Tenn. - eTradeWire -- Cernum Biosciences today released a brief internal sales snapshot showing which peptides are drawing the strongest consumer interest across its catalog of all peptides.

The analysis found that Retatrutide is the most popular peptide, representing approximately 34% of demand. GHK-CU ranks second at approximately 24%. Together, those two products account for more than half of overall peptide demand.

A second tier of popularity includes CJC 1295 no DAC & Ipamorelin Blend at about 10% and BPC-157 at roughly 8%. At the other end of the ranking, the least popular peptides were Kisspeptin-10 and CJC-1295 (No DAC), each accounting for approximately 0.2% of demand, with IGF-1 LR3 also representing less than 1%.

More on eTradeWire News

• Fyt-02 Launches on Kickstarter The Smart Sensor That Turns Any Chair Into a Posture & Movement Track
• EyeCool Therapeutics Announces Publication of First Randomized Controlled Trial of Cooling Device
• Scituate Solar Expert Dave Simmer Hits 1,800 Installations Across South Shore Massachusetts
• Sex, Smoke, and Survival: Let Me Get My Underwear on First by C.J. Striker Lands with Brutal Honesty
• AI Property Management: How AI in Property Management Is Improving Housing Operations

The company said the data reflects clear customer preference for a small number of leading peptides while also showing continued interest across a broader specialty category. More information is available on the company's article about consumer trends.

About Cernum Biosciences

Cernum Biosciences is a purity-focused company dedicated to advancing access to high-quality peptides and supporting innovation in the life sciences sector.